Graphite Bio GRPH Stock
Graphite Bio Price Chart
Graphite Bio GRPH Financial and Trading Overview
| Graphite Bio stock price | 3.18 USD |
| Previous Close | 2.9 USD |
| Open | 2.88 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1200 |
| Day's Range | 2.86 - 2.97 USD |
| 52 Week Range | 1.59 - 4.48 USD |
| Volume | 74.45K USD |
| Avg. Volume | 117.36K USD |
| Market Cap | 169.08M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.6 USD |
GRPH Valuation Measures
| Enterprise Value | -91056448 USD |
| Trailing P/E | N/A |
| Forward P/E | -3.6375 |
| PEG Ratio (5 yr expected) | -0.1 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.61301875 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.902 |
Trading Information
Graphite Bio Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 21.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.48 USD |
| 52 Week Low | 1.59 USD |
| 50-Day Moving Average | 2.9 USD |
| 200-Day Moving Average | 2.89 USD |
GRPH Share Statistics
| Avg. Volume (3 month) | 117.36K USD |
| Avg. Daily Volume (10-Days) | 75.3K USD |
| Shares Outstanding | 58.1M |
| Float | 19.13M |
| Short Ratio | 6.91 |
| % Held by Insiders | 9.51% |
| % Held by Institutions | 83.40% |
| Shares Short | 672.48K |
| Short % of Float | 3.40% |
| Short % of Shares Outstanding | 1.15% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.79% |
| Return on Equity (ttm) | -31.10% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -100982000 USD |
| Net Income Avi to Common (ttm) | -99151000 USD |
| Diluted EPS (ttm) | -1.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 264.1M USD |
| Total Cash Per Share (mrq) | 4.55 USD |
| Total Debt (mrq) | 4.54M USD |
| Total Debt/Equity (mrq) | 1.64 USD |
| Current Ratio (mrq) | 18.849 |
| Book Value Per Share (mrq) | 4.747 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -87814000 USD |
| Levered Free Cash Flow (ttm) | -49947500 USD |
Profile of Graphite Bio
| Country | United States |
| State | CA |
| City | South San Francisco |
| Address | 201 Haskins Way |
| ZIP | 94080 |
| Phone | (650) 484-0886 |
| Website | https://graphitebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 120 |
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH102 for the treatment of beta-thalassemia; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
Q&A For Graphite Bio Stock
What is a current GRPH stock price?
Graphite Bio GRPH stock price today per share is 3.18 USD.
How to purchase Graphite Bio stock?
You can buy GRPH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Graphite Bio?
The stock symbol or ticker of Graphite Bio is GRPH.
Which industry does the Graphite Bio company belong to?
The Graphite Bio industry is Biotechnology.
How many shares does Graphite Bio have in circulation?
The max supply of Graphite Bio shares is 58.24M.
What is Graphite Bio Price to Earnings Ratio (PE Ratio)?
Graphite Bio PE Ratio is 0.00000000 now.
What was Graphite Bio earnings per share over the trailing 12 months (TTM)?
Graphite Bio EPS is 0 USD over the trailing 12 months.
Which sector does the Graphite Bio company belong to?
The Graphite Bio sector is Healthcare.
Graphite Bio GRPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}